Antiplatelet activity of inositol hexaphosphate (IP-6). Mammary tumor inhibition by IP-6: a review. IP-6 in treatment of liver cancer. II. Intra-tumoral injection of IP-6 regresses pre-existing human liver cancer xenotransplanted in nude mice IP-6 in treatment of liver cancer. I. IP-6 inhibits growth and reverses transformed phenotype in HepG2 human liver cancer cell line. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP-6 in HT-29 human colon carcinoma cell line. Novel anticancer function of inositol hexaphosphate: inhibition of human rhabdomyosarcoma in vitro and in vivo. IP-6: a novel anti-cancer agent. Comparison of pure inositol hexaphosphate and high-bran diet in the prevention of DMBA-induced rat mammary carcinogenesis.           Site Requirements